Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;21(9):579-591.
doi: 10.1038/s41568-021-00367-9. Epub 2021 Jun 29.

MYC protein interactors in gene transcription and cancer

Affiliations
Review

MYC protein interactors in gene transcription and cancer

Corey Lourenco et al. Nat Rev Cancer. 2021 Sep.

Abstract

The transcription factor and oncoprotein MYC is a potent driver of many human cancers and can regulate numerous biological activities that contribute to tumorigenesis. How a single transcription factor can regulate such a diverse set of biological programmes is central to the understanding of MYC function in cancer. In this Perspective, we highlight how multiple proteins that interact with MYC enable MYC to regulate several central control points of gene transcription. These include promoter binding, epigenetic modifications, initiation, elongation and post-transcriptional processes. Evidence shows that a combination of multiple protein interactions enables MYC to function as a potent oncoprotein, working together in a 'coalition model', as presented here. Moreover, as MYC depends on its protein interactome for function, we discuss recent research that emphasizes an unprecedented opportunity to target protein interactors to directly impede MYC oncogenesis.

PubMed Disclaimer

References

    1. Meyer, N. & Penn, L. Z. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976–990 (2008). - PubMed - DOI
    1. Kalkat, M. et al. MYC deregulation in primary human cancers. Genes 8, 2–30 (2017). - DOI
    1. Dang, C. V., Reddy, E. P., Shokat, K. M. & Soucek, L. Drugging the “undruggable” cancer targets. Nat. Rev. Cancer 17, 502–508 (2017). - PubMed - PMC - DOI
    1. Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C. & McMahon, S. B. Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 4, 562–568 (2004). - PubMed - DOI
    1. Lin, C. Y. et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56–67 (2012). - PubMed - PMC - DOI

MeSH terms

Substances

LinkOut - more resources